High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome

Gynecologic Oncology

Volumn 128, Issue 3, 2013, Pages 500-505

  Cope, Leslie ^a   Wu, Ren Chin ^b,c   Shih, Ie Ming ^a,b   Wang, Tian Li ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Chromosomal instability; High grade serous carcinoma; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME ABERRATION; DNA DAMAGE; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMAN; MITOSIS; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CYSTADENOCARCINOMA, SEROUS; DNA COPY NUMBER VARIATIONS; FEMALE; GENOME, HUMAN; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873598320     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.031     Document Type: Article

References (36)

1. D.G. Albertson, C. Collins, F. McCormick, and J.W. Gray Chromosome aberrations in solid tumors Nat Genet 34 4 2003 369 376
2. F. Mitelman Recurrent chromosome aberrations in cancer Mutat Res 462 2-3 2000 247 253
3. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
4. K.R. Cho, and I.-M. Shih Ovarian cancer Annu Rev Pathol Mech Dis 4 1 2009 287 313
5. E. Kuhn, R.J. Kurman, R. Vang, A.S. Sehdev, G. Han, and R. Soslow TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma - evidence supporting the clonal relationship of the two lesions J Pathol 226 3 2011 421 426
6. K.T. Kuo, B. Guan, Y. Feng, T.L. Mao, X. Chen, and N. Jinawath Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas Cancer Res 69 9 2009 4036 4042
7. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 7353 2011 609 615
8. A. Favorov, L. Mularoni, L.M. Cope, Y. Medvedeva, A.A. Mironov, and V.J. Makeev Exploring massive, genome scale datasets with the GenometriCorr package PLoS Comput Biol 8 5 2012 e1002529
9. Andrew Kossenkov, Frank J. Manion, Eugene Korotkov, Thomas D. Moloshok, and Michael F. Ochs ASAP: automated sequence annotation pipeline for web-based updating of sequence information with a local dynamic database Bioinformatics 19 5 2003 675 676
10. S.L. Carter, K. Cibulskis, E. Helman, A. McKenna, H. Shen, and T. Zack Absolute quantification of somatic DNA alterations in human cancer Nat Biotechnol 30 5 2012 413 421
11. A. Li, Z. Liu, K. Lezon-Geyda, S. Sarkar, D. Lannin, and V. Schulz GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays Nucleic Acids Res 39 12 2011 4928 4941
12. J.L. Svennevig, O.C. Lunde, J. Holter, and D. Bjørgsvik Lymphoid infiltration and prognosis in colorectal carcinoma Br J Cancer 49 3 1984 375
13. S. Ménard, G. Tomasic, P. Casalini, A. Balsari, S. Pilotti, and N. Cascinelli Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas Clin Cancer Res 3 5 1997 817 819
14. C.S.D. Roxburgh, J.M. Salmond, P.G. Horgan, K.A. Oien, and D.C. McMillan Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer Eur J Cancer 45 12 2009 2138 2145
15. E. Sato, S.H. Olson, J. Ahn, B. Bundy, H. Nishikawa, and F. Qian Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A 102 51 2005 18538 18543
16. J. Hamanishi, M. Mandai, M. Iwasaki, T. Okazaki, Y. Tanaka, and K. Yamaguchi Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer Proc Natl Acad Sci U S A 104 9 2007 3360 3365
17. B. Clarke, A.V. Tinker, C.-H. Lee, S. Subramanian, M. van de Rijn, and D. Turbin Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss Mod Pathol 22 3 2008 393 402
18. N. Turner, A. Tutt, and A. Ashworth Hallmarks of "BRCAness" in sporadic cancers Nat Rev Cancer 4 10 2004 814 819
19. M.C. Haffner, M.J. Aryee, A. Toubaji, D.M. Esopi, R. Albadine, and B. Gurel Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements Nat Genet 42 8 2010 668 675
20. B.-G. Ju, V.V. Lunyak, V. Perissi, I. Garcia-Bassets, D.W. Rose, and C.K. Glass A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription Science 312 5781 2006 1798 1802
21. S.F. Bakhoum, and D.A. Compton Chromosomal instability and cancer: a complex relationship with therapeutic potential J Clin Invest 122 4 2012 1138 1143
22. A. Walther, R. Houlston, and I. Tomlinson Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis Gut 57 7 2008 941 950
23. S.L. Carter, A.C. Eklund, I.S. Kohane, L.N. Harris, and Z. Szallasi A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers Nat Genet 38 9 2006 1043 1048
24. A.J.X. Lee, D. Endesfelder, A.J. Rowan, A. Walther, N.J. Birkbak, and P.A. Futreal Chromosomal instability confers intrinsic multidrug resistance Cancer Res 71 5 2011 1858 1870
25. C. Swanton, B. Nicke, M. Schuett, A.C. Eklund, C. Ng, and Q. Li Chromosomal instability determines taxane response Proc Natl Acad Sci U S A 106 21 2009 8671 8676
26. S.F. Bakhoum, O.V. Danilova, P. Kaur, N.B. Levy, and D.A. Compton Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma Clin Cancer Res 17 24 2011 7704 7711
27. M.C. Haffner, A.M. De Marzo, A.K. Meeker, W.G. Nelson, and S. Yegnasubramanian Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target? Clin Cancer Res 17 12 2011 3858 3864
28. M. Debatisse, B. Le Tallec, A. Letessier, B. Dutrillaux, and O. Brison Common fragile sites: mechanisms of instability revisited Trends Genet 28 1 2012 22 32
29. S.G. Durkin, and T.W. Glover Chromosome fragile sites Annu Rev Genet 41 2007 169 192
30. P.K. Tsantoulis, A. Kotsinas, P.P. Sfikakis, K. Evangelou, M. Sideridou, and B. Levy Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study Oncogene 27 23 2008 3256 3264
31. L.W. Dillon, A.A. Burrow, and Y.-H. Wang DNA instability at chromosomal fragile sites in cancer Curr Genom 11 5 2010 326 337
32. F.A. Barr, H.H.W. Silljé, and E.A. Nigg Polo-like kinases and the orchestration of cell division Nat Rev Mol Cell Biol 5 6 2004 429 440
33. M.M. Donaldson, A.A.M. Tavares, I.M. Hagan, E.A. Nigg, and D.M. Glover The mitotic roles of Polo-like kinase J Cell Sci 114 13 2001 2357 2358
34. N. Takai, R. Hamanaka, J. Yoshimatsu, and I. Miyakawa Polo-like kinases (Plks) and cancer Oncogene 24 2 2005 287 291
35. F. Eckerdt, J. Yuan, and K. Strebhardt Polo-like kinases and oncogenesis Oncogene 24 2 2005 267 276
36. K. Strebhardt, and A. Ullrich Targeting polo-like kinase 1 for cancer therapy Nat Rev Cancer 6 4 2006 321 330